Skip to content
value.today

BrightPath Biotherapeutics Co., Ltd. vs CellSource Co., Ltd.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • BrightPath Biotherapeutics Co., Ltd. and CellSource Co., Ltd. are worth about the same: $49 M and $48 M (market caps of Mar 8, 2026). BrightPath Biotherapeutics Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet. CellSource Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0921842763682020202120222023202420252026BrightPath Biotherapeutics Co., Ltd. 40CellSource Co., Ltd. 24

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBrightPath Biotherapeutics Co., Ltd.
4594.T
CellSource Co., Ltd.
4880.T
Profile
Country🇯🇵 Japan🇯🇵 Japan
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Revenue—$0 M
Net income—$0 M
Altman Z-score zone——
Data as ofMarket cap Mar 2026Market cap Mar 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, BrightPath Biotherapeutics Co., Ltd. or CellSource Co., Ltd.?

BrightPath Biotherapeutics Co., Ltd. and CellSource Co., Ltd. are worth about the same: $49 M and $48 M (market caps of Mar 8, 2026). BrightPath Biotherapeutics Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet. CellSource Co., Ltd.'s value is the last on file, from Mar 8, 2026: no market-data feed is connected for its exchange yet.

Sources#

Every figure on this page comes from these, with the date shown next to it.